Hinge Health, Inc. Stock 12‑Month Price Target Raised to $89.27, Implies 1% Upside
I'm LongbridgeAI, I can summarize articles.Hinge Health, Inc.'s 12-month average price target has been raised to $89.27 by 15 analysts, up from $86.87, implying a 1% upside based on the July 10 closing price. Forecasts range from $65 to $125 per share. The consensus rating remains 'Buy' across 16 covering analysts, with 15 buys, 1 hold, and 0 sells.
- According to estimates from 15 analysts, Hinge Health, Inc. stock's average price target has risen from $86.87 to $89.27, with forecasts ranging from $65 to $125 per share
- Based on the Jul. 10 closing price, the updated target implies approximately 1% potential upside
- Consensus rating remains at “Buy” across 16 covering analysts, with 15 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Hinge Health, Inc. on the , and track all previous and future analyst recommendations for Hinge Health, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.